The putative seven-transmembrane (TM) domains have been the structural hallmark for the superfamily of heterotrimeric G protein-coupled receptors (GPCRs) that regulate a variety of cellular functions by mediating a large number of extracellular signals. Five-TM GPCR mutants of chemokine receptor CCR5 and CXCR4, the Nterminal segment of which connected directly to TM3 as a result of a deletion of TM1-2 and the first intracellular and extracellular loops, have been obtained in this study. Laser confocal microscopy and f low cytometry analysis revealed that these five-TM mutant GPCRs were expressed stably on the cell surface after transfection into human embryonic kidney 293 cells. The five-TM CCR5 and CXCR4 functioned as normal chemokine receptors in mediating chemokinestimulated chemotaxis, Ca 2؉ inf lux, and activation of pertussis toxin-sensitive G proteins. Like the wild-type GPCRs, the five-TM mutant receptors also underwent agonist-dependent internalization and desensitization and were subjected to regulation by GPCR kinases and arrestins. Our study indicates that five-TM domains, at least in the case of CCR5 and CXCR4, appear to meet the minimum structural requirements for a functional GPCR and suggests possible existence of functional five-TM GPCRs in nature during evolution.
The heterotrimeric GTP binding protein-coupled receptors (GPCRs) constitute a large and diverse superfamily of signaling molecules. Of about 19,000 ORFs in the genome of Caenorhabditis elegans, more than 1,000 are coded for known or unknown GPCRs (1) . GPCRs play fundamental roles in regulation of a variety of cell functions by mediating a huge number of extracellular signals such as hormones, neurotransmitters, chemokines, and sensory stimuli (2, 3) . Chemokine receptors belong to the GPCRs superfamily and are classified as CC chemokine receptors (CCRs) or CXC chemokine receptors (CXCRs) based on chemokine structures (4, 5) . Chemokine receptors mediate many vital functions of chemokines, and it was demonstrated recently that CCR5, CCR2B, CCR3, and CXCR4 are the essential coreceptors on the cell surface for HIV-1 fusion and infection (6, 7) .
The GPCR superfamily is evolutionarily conserved and structurally characterized by its possessing putative seventransmembrane (TM) domains with an extracellular N terminus and a cytoplasmic C terminus (8) . The universal adoption of the conserved seven-TM structure by GPCRs, which consequently confers three intracellular and three extracellular loops along with a TM core, generally is speculated as the minimum necessity to achieve their structural stability and functional diversity (3) . None of nearly 2,000 GPCRs identified in prokaryotes and eukaryotes to date is known to contain fewer than seven TM domains. Evidence accumulated from studies with ''split'' GPCRs also indicates that coexpression of receptor fragments with complementary TMs is necessary to reconstitute functional GPCRs in the cases of receptors such as bacteriorhdopsin, rhdopsin, ␤-adrenergic, M2 and M3 muscarinic receptors, and V2 vasopressin (9) . Genetic mutations of chemokine receptors were reported recently. Natural mutants of chemokine receptor CCR5 lacking the last three or five TMs as a result of a deletion or single point mutation in the ORF are nonfunctional (10, 11) . The current study, however, clearly demonstrated that chemokine receptors with only five TMs appear to act as functional GPCRs in the aspects of receptor expression, signaling, internalization, and desensitization.
MATERIALS AND METHODS

Materials.
Recombinant human RANTES (regulated on activation normal T-cell expressed and secreted), forskolin, 1-methyl-3-isobutylxan-thine, GDP, GTP␥S, BSA, pertussis toxin (PTX), and phorbol-12-myristate-13-acetate (PMA) were purchased from Sigma. Stromal cell-derived factor 1␣ (SDF-1␣) was from PharMingen. Cloning and Plasmid Construction. The full-length cDNA encoding the wild-type CXCR4 was cloned by reverse transcription-PCR (RT-PCR) from THP-1 cells using primers designed based on the published sequences (GenBank accession no. X71635), and the wild-type human CCR5 was cloned as described (12) . A minor PCR product of approximately 800 bp, in addition to the expected product of 1,020 bp, was generated in PCRs to amplify CCR5 by using human leukocyte cDNAs as a template. The origin of the minor PCR product was not known; it was probably a result of the suboptimal conditions of the PCR. However, after being cloned and sequenced, the shorter PCR product was found to encode a CCR5 mutant lacking 72 aa residues (Leu-37-Gly-107). Subsequently, a similar mutation of CXCR4 with a deletion of 72 PNAS is available online at www.pnas.org. This paper was submitted directly (Track II) to the Proceedings office. Abbreviations: TM, transmembrane; GPCR, G protein-coupled receptor; CCR, CC chemokine receptor; CXCR, CXC chemokine receptor; HA, hemagglutinin; RANTES, regulated on activation normal T cell expressed and secreted; SDF-1␣, stromal cell-derived factor 1␣; GRK, G protein-coupled receptor kinase; HEK, human embryonal kidney; PTX, pertussis toxin; PMA, phorbol-12-myristate-13-acetate. † K.L., P.W., and J.Z. contributed equally to this work. ¶ aa (Ile-43-Val-114) corresponding to those in CCR5 was purposely designed and the mutant receptor cDNA was prepared by PCR using the wild-type construct as a template. The amplified human chemokine receptor cDNA fragments were cloned into a modified pcDNA3 vector (Invitrogen) with the sequence of HA epitope tag at the 5Ј end. Go␣1 and ␤-arrestin 2 were amplified by RT-PCR using human brain mRNA as a template and cloned into pcDNA3. The authenticity of the DNA sequences was confirmed by sequencing. Expression plasmids for human ␤-arrestin 1 (13), human Gi␣2 (14) , and bovine G protein-coupled receptor kinase (GRK) 2 and GRK5 (15) were as described.
Cell Culture and Transfection. Human embryonic kidney (HEK) 293 cells (American Type Culture Collection) were cultured in MEM (GIBCO͞BRL) supplemented with 10% heat-inactivated FBS. HEK293 cells (1 ϫ 10 6 ) plated in a 60-mm tissue culture dish were transfected with 5 g DNA by using the calcium phosphate-DNA coprecipitation method and used 48 hr after transfection unless indicated otherwise. For chemotaxis assay, the transfected HEK293 cells were placed in medium containing 1 mg͞ml Geneticin (GIBCO͞ BRL) 48 hr after transfection, and the transfectants were maintained in the same medium to select Geneticin-resistant cells stably expressing chemokine receptors. The expression of transfected receptors on the Geneticin-resistant cells was evaluated by fluorescence-activated cell sorting using 12CA5.
Chemotaxis Assay. The assays were performed in blind-well chambers (Neuroprobe, Gaithersburg, MD) as described (16) . The agonist was added to the lower wells, and the polycarbonate membrane (pore size 8 m, Poretics) in the upper chamber was coated with collagen. The HEK293 cells were resuspended at a density of 5 ϫ 10 6 per ml of MEM containing 0.1% BSA, and 200 l of cell suspension was added to the upper chamber. After incubation at 37°C for 6 hr, the cell suspension in the upper chamber was removed, and the membrane was fixed and stained. For each agonist concentration tested, cells migrated through to the underside of the membrane were counted in eight high-power fields, in a blinded fashion. The migration index for each experiment was calculated as the mean number of cells that migrated toward medium containing agonist divided by mean number of cells that migrated toward medium containing BSA only.
Ca 2؉ Inf lux Determination. As described (17) contained in the homogenized cell lysate was determined in a liquid scintillation spectrophotometer, and the protein content was determined according to Lowry's method. The Ca 2ϩ influx across the plasma membrane in each sample was calculated as: ([Ca 2ϩ ] total ͞protein sample ) ϫ (cpm sample ͞cpm total ).
[ 35 S]GTP␥S Binding Assay. The assay was carried out as described (12) . Cells were lysed in 5 mM Tris⅐HCl, pH 7.5͞5 mM EDTA͞5 mM EGTA at 4°C. The membrane pellet resulted from a 30,000 ϫ g centrifugation was resuspended, and aliquots containing 10 g protein were incubated at 30°C for 1 hr in 50 mM Tris⅐HCl, pH 7.5͞1 mM EDTA͞5 mM MgCl 2 ͞100 mM NaCl͞40 M GDP͞0.5 nM [ cAMP Assay. Cells were challenged with agonist in the presence of 10 M forskolin and 500 M 1-methyl-3-isobutylxanthine at 37°C for 10 min. The reaction was terminated with 1 N perchloric acid, which then was neutralized with 2 M K 2 CO 3 . The cAMP level of each sample was determined by using RIA as described (18) . Data were averages of duplicate samples and presented as a percentage of control,
. cAMP (forskolin ϩ agonist) is cAMP level in the presence of forskolin and agonist, cAMP (basal) is cAMP level in the absence of forskolin and agonist, and cAMP (forskolin) is cAMP level in the presence of forskolin alone.
Flow Cytometry. Cells were incubated with 12CA5 (5 g͞ ml) in PBS containing 2% BSA at 4°C for 1 hr. The presence of HA-tagged chemokine receptors on the cell surface was detected by incubation with FITC-conjugated goat anti-mouse IgG (Tago). The cells were analyzed on a FACSCalibur flow cytometer. Basal cell fluorescence intensity was determined with cells stained with the secondary antibody alone.
Immunof luorescence Microscopy. Immunofluorescence microscopy was done as described (19) . After stimulation with the agonists at 37°C for 30 min, the cells grown on coverslips were fixed in 1% polyformaldehyde for 20 min and incubated with methanol at Ϫ20°C for 20 min. Then the cells were treated with 12CA5, and the presence of HA-tagged chemokine receptors was detected with FITC-conjugated goat anti-mouse IgG. The control experiments were done with mocktransfection cells. Images were recorded by using a Leica TCS NT laser confocal scanning microscope.
Immunoprecipitation and Western Blotting. The experiment was performed as described (20) . Briefly, cells were lysed in 20 mM Tris⅐HCl, pH 7.4͞150 mM NaCl͞0.4% digitonin on ice for 45 min. The lysate was centrifuged at 12,000 ϫ g for 30 min, and the supernatant was incubated with 0.5 g 12CA5 and Protein A-Sepharose (Amersham Pharmacia) on ice for 4 hr. After washing, the immunocomplexes absorbed onto Protein A-Sepharose were eluted in 50 mM Tris⅐HCl (pH 7.4), 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, and 0.01% bromophenol blue and subjected to Western blot analysis using 12CA5 as described (13) .
RESULTS
Molecular Cloning and Cell Surface Expression of the Five-TM Receptors.
A chemokine receptor CCR5 mutant (mCCR5) bearing a 216-bp deletion in the ORF and encoded for a receptor lacking 72 aa residues was unexpectedly obtained in our effort to clone chemokine receptor CCR5 by PCR. Interestingly, analysis of the deduced amino acid sequence revealed that the mutant receptor lacks the region (Leu-36-Gly-107) coding for the first and second putative TM and the first intracellular and extracellular loops of GPCR (Fig. 1A) . Similar mutation of another chemokine receptor CXCR4 with deletion of 72 aa residues from Ile-43 to Val-114 (mCXCR4) then was purposely designed and constructed (Fig.  1 A) . As shown in Fig. 1B , both mutant chemokine receptors possess only the last five TMs, according to the twodimensional models of CCR5 and CXCR4 (21) , with the intact N terminus directly connected to the third TM.
Certain mutations in GPCR impair stability of the receptor on the membrane; therefore, these mutant receptors are unable to translocate to cell surface. It has been reported that CCR5-⌬32 mutant encoding for a truncated receptor and even CCR5 with certain point mutations express poorly on the cell surface (10, 22) . The expression of the five-TM chemokine receptor mutants therefore were examined in HEK293 cells. First, immuoprecipitation experiments confirmed expression of the wild-type and the truncated chemokine receptors in HEK293 cells (Fig. 2A) . Surface expression of the wild-type Cell Biology: Ling et al.
Proc. Natl. Acad. Sci. USA 96 (1999) and the mutant chemokine receptors CCR5 and CXCR4 tagged with HA at their N termini (23, 24) was detected by laser confocal microscopy and flow cytometry after immunofluorescence staining with 12CA5. The results show that both five-TM receptor mCCR5 and mCXCR4 were expressed stably on the plasma membranes at a level comparable to their wild-type seven-TM counterparts (Fig. 2 B-F) . Agonist-Stimulated Receptor Internalization. Once stimulated with receptor agonist, most GPCRs undergo rapid endocytosis, termed as internalization (25) . As detected with confocal immunofluoresence microscopy and fluorescenceactivated cell sorting, the wild-type and the mutant chemokine receptors CCR5 or CXCR4 expressed on HEK293 cell surface quickly internalized in the response to the stimulation by RANTES (agonist of CCR5) or SDF-1␣ (agonist of CXCR4) (Fig. 2 B-F) . Chemokine treatment of 30 min caused approximately 20% reduction in cell surface fluorescence in cells expressing wCCR5 or mCCR5 and more than 40% reduction in cells expressing wCXCR4 or mCXCR4 (Fig. 2F) . The above results indicate that the five-TM mutant chemokine receptors also undergo agonist-dependent internalization as their wildtype counterparts do and that TM1 and TM2 as well as the first intracellular and extracellular loops are not required for internalization of CCR5 and CXCR4.
Receptor-Mediated Cellular Responses to Chemokines. GPCR-mediated cellular responses critically depend on the functional interaction of receptor and its agonist and the subsequent G protein activation induced. The potencies and efficacies of the receptor agonist RANTES and SDF-1␣ to stimulate the mutant chemokine receptors were not significantly different from those for wCCR5 and wCXCR4 as measured with GTP␥S binding and cAMP assays (Fig. 3) . Similar results also were obtained by using MIP-1␤, another agonist of CCR5 (data not shown). Other receptor-mediated cellular responses to chemokines also were examined. As shown in Fig. 3, the cells expressing mCCR5 and mCXCR4 showed increased migration (C) and extracellular calcium influx (D) in response to chemokine stimulation at levels comparable to the wild-type controls. These data indicate that (12) . Stimulation of chemokine receptors activate inhibitory G proteins (12) , which induce chemotaxis (16) . As shown in Fig. 4, pretreat cells cotransfected with receptors and ␣ subunits of either Gi or Go demonstrate that the mutant chemokine receptors couple to these two PTX-sensitive G proteins just as well as their wild-type counterparts (Fig. 4 B and C) . Our data suggest that receptor-G protein coupling is not affected by the truncation and imply that the first intracellular loop of CCR5 and CXCR4 is not involved in the coupling of receptor to these G proteins.
Receptor Desensitization and Interaction with Receptor Kinases and Arrestins. Agonist-dependent desensitization of GPCR has been under extensive investigation. Some of the underlying mechanisms have been clearly depicted, and GRKs and arrestins have been shown to play important roles (25) . Previous research by our laboratory (12) and Aramori et al. (23) showed that chemokine receptors desensitize after agonist pretreatment, and this process involves GRKs and ␤-arrestins. Chemokine-induced desensitization of the wild-type and the mutant receptors was tested in this study. As shown in Fig. 5A , the responsiveness of both the wild-type and the five-TM mutant receptors reduced greatly after preincubation with the agonist of the corresponding receptor, suggesting the deletion of 72 aa residues apparently does not affect the feedback regulation of CCR5 and CXCR4. Chemokine or PMA treatment causes phorsphorylation and desensitization of chemokine receptors (24) . As shown in Fig. 5B , treatment with protein kinase C (PKC) activator PMA mimicked the agonist pretreatment whereas it had no significant effect on basal adenylyl cyclase activity (Fig. 5B) , indicating recognition and regulation of the wild-type seven-TM and the mutant five-TM chemokine receptors by PKC in these cells (24) . Furthermore, coexpression of the chemokine receptors with either GRKs (2 or 5) or ␤-arrestins (1 or 2) significantly attenuated the receptor-mediated inhibition of cAMP, and no significant difference between the wild-type and mutant chemokine receptors was observed (Fig. 5 C and D) . These results thus indicate that the interaction of the receptor with GRKs or arrestins is not altered by the truncation, and the deleted TM1-2 region is not critical for regulation of the receptor responsiveness by GRKs and arrestins.
DISCUSSION
The structure and function relationship of GPCRs has attracted a great deal of attention because of the importance of GPCRs in regulation of numerous cellular functions. The putative seven-TM structure is considered as the molecular fingerprint shared by all known GPCRs and therefore has been widely used to identify novel GPCRs even with unknown functions. No GPCR with fewer than seven TMs has been reported to date, which has led to a reasonable speculation that five TMs may be insufficient whereas nine TMs would be more than enough to form a stable, yet flexible, TM core (3). The current study, however, clearly demonstrates that five-TM chemokine receptors CCR5 and CXCR4 function in many aspects tested indistinguishably from their seven-TM counterparts and indicate that the five-TM structure is feasible within the chemokine receptor family. Thus, our study suggests that the five-TM core structure appears sufficient for a functional GPCR with enough stability at least in the case of chemokine receptors.
Several distinct modes of GPCR-ligand binding have been observed, which depend on whether ligand binds to the TM core, to both core and extracellular loops, to extracellular (27) , and the first extracellular loop and TM2 consist of parts of the ligand binding sites in formyl peptide receptors (3). Agonist-induced conformational changes in GPCRs lead to activation of G proteins selectively coupled to these receptors and thus transduce the extracellular signals into specific cellular responses. Numerous studies have indicated that in most cases the second and third intracellular loops of GPCRs are the major sites for receptor to interact with G proteins, and the amino acids residues in these regions are the primary determinants of the selectivity of G protein coupling (2) . The current study provides additional evidence that the first intracellular loop is not critically involved in the coupling of chemokine receptors to PTX-sensitive G proteins. Furthermore, the selectivity of coupling of the chemokine receptors to either Gi or Go proteins seems unaffected by the deletion of TM1-2, at least under the conditions of overexpression of G proteins. It is also of great interest to notice that the feedback regulation of the five-TM mutant chemokine receptors, namely agonist-dependent internalization and desensitization of receptors, seems indistinguishable from their seven-TM counterparts and that their functional interactions with other signal molecules such as GPCR kinases, arrestins, or protein kinase C apparently were not altered. Taken together, data from this study suggest that the five-TM domain structure appears to be sufficient for a functional GPCR, at least in the cases of CCR5 and CXCR4.
On the extracellular surface, the seven-TM domains in GPCRs are proposed to be arranged counterclockwise as a cluster, in which TM1 and TM2 are somewhat apart from the rest of the five TMs (28) . This arrangement may render the structural basis for the separation of TM1-2 from TM3-7 as an independent folding unit in the ''split'' GPCRs (9) or as a functional dispensable part in the current study of chemokine receptors. However, the question still remains unanswered: why has the seven-TM core been universally adopted by all GPCRs identified to date, and in other words, why were five-TM GPCRs unable to evolve naturally even if the seven-TM receptors emerged first in evolution? The current study suggests the possible existence of functional GPCRs with five-TM domains in nature that have not been discovered yet because of the limits of our knowledge and methodology. Otherwise, there has to be some unknown restraint to prevent natural mutations of five-TM GPCRs from occurring and propagating. The lack of a sufficient size and versatility for the five-TM GPCRs to offer a great number of specificities in response to so many diverse signals (3) could be one such reason.
